N. W. (Bill) Jasper Jr. elected to Board of Directors
Dec 03, 2013
SAN DIEGO, CA, December 03 2013: N. W. (Bill) Jasper Jr. was elected to the Board of Directors of BioQuiddity Incorporated in December 2013. The retired president and Chief Executive Officer of Dolby Laboratories led the transformation of Dolby from a small technology innovator in 1979 to its initial public offering in 2005. The international technology giant reported sales of nearly $1 billion in 2012.
Mr. Jasper, an active resident of Sonoma California, said: "The worldwide demand for safe, effective healthcare has increased costs to patients, providers and payers. BioQuiddity has designed a proprietary infusion system platform to reduce costs and improve quality of life for patients at home, in hospitals, nursing facilities, and in civic disasters, the battlefield, and developing countries."
Joshua Kriesel PhD, President and CEO of BioQuiddity stated: "Mr. Jasper's experience in corporate governance, finance, technology transformation and licensing adds to the Company's distinguished Board of Directors and Medical Advisors."
Mr. Jasper earned an MBA from the University of California Berkeley and a B.S. in Industrial Engineering from Stanford University.
BioQuiddity is a privately held specialty pharmaceutical company focused on developing and commercializing ready‐to‐use infusible pharmaceuticals. The Company's infusion platform addresses some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQuiddity's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit‐dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. West Pharmaceutical Services, an existing strategic partner of BioQuiddity's, will be assembling the ready‐to‐use infusion systems.
BioQuiddity Contact Information:
President and CEO
Chief Financial Officer
Integrated Corporate Relations, Inc (ICR)